Carregant...
Tumour MLH1 promoter region methylation testing is an effective pre-screen for Lynch Syndrome (HNPCC)
BACKGROUND & AIMS: Lynch syndrome patients have DNA mismatch repair deficiency and up to 80% life-time risk of colorectal cancer. Screening of mutation carriers reduces colorectal cancer incidence and mortality. Selection for constitutional mutation testing relies on family history (Amsterdam an...
Guardat en:
| Publicat a: | J Med Genet |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5159427/ https://ncbi.nlm.nih.gov/pubmed/25280751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2014-102552 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|